Clinical Trial Update: Efficacy of Methylprednisolone Pulses in Neuroendocrine Celles Hyperplasia of Infancy : An Early Phase Study [Phase 2]

View source ↗

Summary

A Phase 2 study is evaluating the efficacy of methylprednisolone pulses in neuroendocrine cell hyperplasia of infancy. The trial is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroendocrine Cell Hyperplasia of Infancy

Drugs mentioned

• METHYLPREDNISOLONE (methylprednisolone)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Neuroendocrine Cell Hyperplasia of Infancy | Phase 2 | Status: RECRUITING